Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

MicuRx reports results from second phase II trial of MRX-I in ABSSSI

Nov. 4, 2015

Emory University and Cocrystal Pharma introduce HCV NS5A inhibitors

Nov. 4, 2015

Janssen R&D Ireland reports anti-RSV agents

Nov. 4, 2015

Regulus expands development of RG-101

Nov. 4, 2015

Antimalarial AQ-13 receives U.S. orphan drug designation

Nov. 4, 2015

University of Oxford starts first-in-human study of prime-boost malaria vaccine

Nov. 3, 2015

Preclinical studies of Shigellosis-typhoid bivalent vaccine

Nov. 2, 2015

Phase I data for dengue purified inactivated vaccine

Oct. 30, 2015

Arbutus provides update on HBV pipeline

Oct. 30, 2015

Vaxart awarded BARDA contract to support development of influenza tablet vaccine

Oct. 30, 2015

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...